DEA Intends to Restrict Imports and Exports of Six Synthetic Cannabinoids
The Drug Enforcement Administration has announced its intent to temporarily include six synthetic cannabinoids into schedule I of the Controlled Substances Act. Synthetic cannabinoids are chemicals synthesized in laboratories that mimic the biological effects of delta-9-tetrahydrocannabinol, the main psychoactive ingredient in marijuana. The specific substances targeted under this action are:
- methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate [5F-ADB; 5FMDMB-PINACA];
- methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate [5F-AMB];
- N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide [5F-APINACA, 5F-AKB48];
- N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide [ADB-FUBINACA];
- methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate [MDMBCHMICA, MMB-CHMINACA]; and
- methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate [MDMB-FUBINACA].
The DEA notes that this action is based on a finding that the placement of these synthetic cannabinoids into schedule I is necessary to avoid an imminent hazard to the public safety. Any final order, which the DEA states will be issued as soon as possible after the expiration of a 30-day layover period, will impose the administrative, civil and criminal sanctions and regulatory controls applicable to schedule I substances under the CSA on the manufacture, distribution, possession, importation, exportation, research and conduct of instructional activities of these synthetic cannabinoids.